136 related articles for article (PubMed ID: 35341118)
1. Synthesis and evaluation of chitosan based controlled release nanoparticles for the delivery of ticagrelor.
Shahid N; Erum A; Zaman M; Tulain UR; Shoaib QU; Malik NS; Kausar R; Rashid A; Rehman U
Des Monomers Polym; 2022; 25(1):55-63. PubMed ID: 35341118
[TBL] [Abstract][Full Text] [Related]
2. pH-Responsive Nanocomposite Based Hydrogels for the Controlled Delivery of Ticagrelor; In Vitro and In Vivo Approaches.
Shahid N; Erum A; Zaman M; Tulain UR; Shoaib QU; Majeed A; Rasool MF; Imran I; Alshehri S; Noorani B; Alqahtani F
Int J Nanomedicine; 2021; 16():6345-6366. PubMed ID: 34556985
[TBL] [Abstract][Full Text] [Related]
3. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.
Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA
Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic variables of medium molecular weight cross linked chitosan nanoparticles to enhance the bioavailability of 5-fluorouracil and reduce the acute oral toxicity.
Sethi A; Ahmad M; Huma T; Ahmad W
Drug Deliv; 2021 Dec; 28(1):1569-1584. PubMed ID: 34291722
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Low Molecular Weight Cross Linked Chitosan Nanoparticles, to Enhance the Bioavailability of 5-Flourouracil.
Sethi A; Ahmad M; Huma T; Khalid I; Ahmad I
Dose Response; 2021; 19(2):15593258211025353. PubMed ID: 34377107
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-Tripolyphosphate Nanoparticles Prepared by Ionic Gelation Improve the Antioxidant Activities of Astaxanthin in the In Vitro and In Vivo Model.
Kim ES; Baek Y; Yoo HJ; Lee JS; Lee HG
Antioxidants (Basel); 2022 Feb; 11(3):. PubMed ID: 35326128
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate:
Aljaeid BM; El-Say KM; Hosny KM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977
[No Abstract] [Full Text] [Related]
9. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of chitosan nanoparticles containing an indanonic tricyclic spiroisoxazoline derivative using ion-gelation method: an
Abolhasani A; Heidari F; Abolhasani H
Drug Dev Ind Pharm; 2020 Oct; 46(10):1604-1612. PubMed ID: 32812474
[TBL] [Abstract][Full Text] [Related]
11. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
Kumar J; Newton AMJ
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
[TBL] [Abstract][Full Text] [Related]
12. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
13. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
Kushwaha K; Dwivedi H
Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624
[TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration.
Abruzzo A; Giordani B; Miti A; Vitali B; Zuccheri G; Cerchiara T; Luppi B; Bigucci F
Int J Pharm; 2021 Sep; 606():120874. PubMed ID: 34252521
[TBL] [Abstract][Full Text] [Related]
15. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
16. Chitosan based controlled release drug delivery of mycophenolate mofetil loaded in nanocarriers system: synthesis and
Zaman M; Iqbal A; Haider Rizvi SF; Hussain MA; Jamshaid T; Jamshaid M
Drug Dev Ind Pharm; 2021 Mar; 47(3):477-483. PubMed ID: 33621153
[No Abstract] [Full Text] [Related]
17. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel.
Al-Kassas R; Wen J; Cheng AE; Kim AM; Liu SSM; Yu J
Carbohydr Polym; 2016 Nov; 153():176-186. PubMed ID: 27561485
[TBL] [Abstract][Full Text] [Related]
18. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Correlation Between Drug Physical Properties and Physical Characteristics and Drug Entrapment Efficiencies of Chitosan-TPP Nanoparticles.
Jaradat A; Obeidat WM
J Pharm Sci; 2023 Dec; 112(12):3185-3196. PubMed ID: 37751806
[TBL] [Abstract][Full Text] [Related]
20. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
